EPA Approves Emergency Exemption for Antiviral Air Treatment

WASHINGTON (January 15, 2021) — Today, the U.S. Environmental Protection Agency (EPA) announced approval of an emergency exemption request for use of Grignard Pure, as an additional tool in limited use situations to aid in the fight against COVID-19. EPA is issuing an emergency exemption for Grignard Pure to be used in certain indoor spaces where social distancing can be challenging. Use of this product does not eliminate the need…

EPA Awards Section 18 Public Health Emergency Exemption to Grignard Pure™ For First Antimicrobial Air Treatment Solution Proven Effective Against COVID-19

RAHWAY, N.J. (January 15, 2021) — Grignard Pure today announced that its Grignard Pure™ product has received approval from the U.S. Environmental Protection Agency (EPA) as the first and only EPA-approved antimicrobial air treatment solution designed to significantly reduce the viral load of the SARS-CoV-2 virus in the air, where transmission is most likely. The EPA…

Luminator Technology Group and Grignard Company Partner to Deliver Innovative Air Treatment Solution for Public Transit Systems Amid Coronavirus Pandemic

RAHWAY, N.J. & PLANO, Texas (June. 24, 2020) — Grignard Company, a manufacturer of atmospheric effect solutions, and Luminator Technology Group (Luminator), a global leader in transit technology and communication solutions, today announced a partnership focused on providing new safety offerings for public transit amid the ongoing coronavirus pandemic. Luminator will provide the “Grignard Pure” air…

Grignard Company Seeks Federal and State Government Approvals on Atmospheric Haze Product Expected to Inactivate Coronavirus

RAHWAY, N.J. (April 29,  2020). —  Grignard Company, a manufacturer of atmospheric effect solutions, announces that it is seeking approval from federal and state agencies for its “Grignard Pure” product as an atmospheric viricide. Grignard Pure creates a light atmospheric haze throughout an indoor space that inactivates enveloped viruses such as the novel coronavirus on…